Skip to main content
. 2017 Aug 11;8(46):81591–81603. doi: 10.18632/oncotarget.20189

Table 1. Brief history of PDT.

Year Individuals Events
1841 Scherer Discovery of hematoporphyrin by removing iron from dried blood
1861–1871 L. Pasteur and P. Bert Discovery of phototoxicity
1867 J.L.W. Thudichum Fluorescence spectrum of this red substance (hematoporphyrin) as well as fluorescence.
1871 F.Hoppe-Seyler Naming of red substance (hematoporphyrin).
1874 Schultz Description of a porphyria patient (errors in heme biosynthesis).
1895–1903 N.R.Finsen Phototherapy (Nobel prize in 1903)
1897–1904 O.Raaband H. von Tappeiner First reports on phototherapy
1904 H. von Tappeiner Introduction of the term “photodynamic action”
1903–1905 First “before-and-after” photographs of patients (eosin+light)
1908–1913 W.Hausmann, F.Meyer-Betz Many PDT experiments with hematoporphyrin on paramecia, erythrocytes, mice, guinea pigs, and humans.
1924 A.Policard saw red porphyrin fluorescence in tumors and first observation from tumors
1925 H.Fischer Examination of porphyrins (Nobel prize in 1929).
1945 S.Scwarz Radiosensitization with porphyrins.
1959 D.Harman Proposed the free radical theory of ageing and disease.
1960–1967 R.Lipson E.Baldes Synthesis of HpD.
1970 H.Kautsky G.Herzberg Active oxygen.
1975 Z.Malik M.Djaldetti ALA for PpIX induction.
1983–1993 T.J.Dougherty, et al. Photofrin®.
1990 J.Kennedy R.Pottier Clinical application of ALA.